These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8201389)

  • 1. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.
    Abbruzzese JL; Abbruzzese MC; Hess KR; Raber MN; Lenzi R; Frost P
    J Clin Oncol; 1994 Jun; 12(6):1272-80. PubMed ID: 8201389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?
    Lenzi R; Hess KR; Abbruzzese MC; Raber MN; Ordoñez NG; Abbruzzese JL
    J Clin Oncol; 1997 May; 15(5):2056-66. PubMed ID: 9164218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma.
    Hess KR; Abbruzzese MC; Lenzi R; Raber MN; Abbruzzese JL
    Clin Cancer Res; 1999 Nov; 5(11):3403-10. PubMed ID: 10589751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unknown primary tumors metastatic to liver.
    Ayoub JP; Hess KR; Abbruzzese MC; Lenzi R; Raber MN; Abbruzzese JL
    J Clin Oncol; 1998 Jun; 16(6):2105-12. PubMed ID: 9626210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.
    van der Gaast A; Verweij J; Planting AS; Hop WC; Stoter G
    J Clin Oncol; 1995 Jul; 13(7):1720-5. PubMed ID: 7541451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
    Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
    Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
    Hainsworth JD; Johnson DH; Greco FA
    J Clin Oncol; 1992 Jun; 10(6):912-22. PubMed ID: 1375284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.
    Abbruzzese JL; Abbruzzese MC; Lenzi R; Hess KR; Raber MN
    J Clin Oncol; 1995 Aug; 13(8):2094-103. PubMed ID: 7636553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
    Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
    Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
    Trivanović D; Petkovic M; Stimac D
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.
    Nordquist LT; Simon GR; Cantor A; Alberts WM; Bepler G
    Chest; 2004 Aug; 126(2):347-51. PubMed ID: 15302716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.
    Ponce Lorenzo J; Segura Huerta A; Díaz Beveridge R; Giménez Ortiz A; Aparisi Aparisi F; Fleitas Kanonnikoff T; Richart Aznar P; de la Cueva Sapiña H; Montalar Salcedo J
    Clin Transl Oncol; 2007 Jul; 9(7):452-8. PubMed ID: 17652059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
    Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
    Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
    J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic protocol for unknown primary cancers. Review of 157 cases].
    Antuña Egocheaga A; López González ML; Lobo Fernández J; Fernández Bustamante J; Moris de la Tassa J; Cueto Espinar A
    An Med Interna; 2002 Aug; 19(8):405-8. PubMed ID: 12244787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with cancer of unknown primary: a retrospective analysis of 223 patients with adenocarcinoma or undifferentiated carcinoma.
    Löffler H; Puthenparambil J; Hielscher T; Neben K; Krämer A
    Dtsch Arztebl Int; 2014 Jul; 111(27-28):481-7. PubMed ID: 25138727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
    Deonarine P; Han S; Poon FW; de Wet C
    Scott Med J; 2013 Aug; 58(3):154-62. PubMed ID: 23960054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.